These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9952155)

  • 1. The pulmonary first-pass uptake of five nondepolarizing muscle relaxants in the pig.
    Beaufort TM; Proost JH; Houwertjes MC; Roggeveld J; Wierda JM
    Anesthesiology; 1999 Feb; 90(2):477-83. PubMed ID: 9952155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of the differences in the time to onset of action between rocuronium and vecuronium.
    Nava-Ocampo AA; Velázquez-Armenta Y; Moyao-García D; Salmerón J
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):125-30. PubMed ID: 16445711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of priming with vecuronium and rocuronium on young and elderly patients.
    Aziz L; Jahangir SM; Choudhury SN; Rahman K; Ohta Y; Hirakawa M
    Anesth Analg; 1997 Sep; 85(3):663-6. PubMed ID: 9296427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potency of new muscle relaxants on recombinant muscle-type acetylcholine receptors.
    Paul M; Kindler CH; Fokt RM; Dresser MJ; Dipp NC; Yost CS
    Anesth Analg; 2002 Mar; 94(3):597-603; table of contents. PubMed ID: 11867382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ORG 9426, succinylcholine or vecuronium: which agent provides "overall superiority" for short outpatient procedures.
    Ginsburg R; Lippmann M
    Anesth Analg; 1993 Apr; 76(4):904-5. PubMed ID: 8096683
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent advances in myorelaxant therapy.
    Meakin GH
    Paediatr Anaesth; 2001; 11(5):523-31. PubMed ID: 11696115
    [No Abstract]   [Full Text] [Related]  

  • 8. The isolated heart-lung preparation in the cat. An in situ model to study the role of the lungs in the disposition of drugs.
    Beaufort AM; Wierda JM; Houwertjes MC; Kleef UW; Meijer DK
    J Pharmacol Toxicol Methods; 1993 Jun; 29(3):147-56. PubMed ID: 8103378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuromuscular blocking effects of Org 9426 (rocuronium bromide); a comparative study with vecuronium bromide in Japanese patients].
    Shingu K; Masuzawa M; Omote K; Namiki A; Kikuchi H; Kawamada M; Sato S; Kimura T; Hatano N; Nakatsuka H; Morita K; Hara T; Kanmura Y; Takeda J
    Masui; 2006 Sep; 55(9):1140-8. PubMed ID: 16984012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the pharmacodynamics of rocuronium and vecuronium during halothane anaesthesia.
    Booth MG; Marsh B; Bryden FM; Robertson EN; Baird WL
    Anaesthesia; 1992 Oct; 47(10):832-4. PubMed ID: 1359803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model for determining the influence of hepatic uptake of nondepolarizing muscle relaxants in the pig.
    Motsch J; Hennis PJ; Zimmermann FA; Agoston S
    Anesthesiology; 1989 Jan; 70(1):128-33. PubMed ID: 2563214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molar potency is predictive of the speed of onset of neuromuscular block for agents of intermediate, short, and ultrashort duration.
    Kopman AF; Klewicka MM; Kopman DJ; Neuman GG
    Anesthesiology; 1999 Feb; 90(2):425-31. PubMed ID: 9952148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iontophoretic study of speed of action of various muscle relaxants.
    Min JC; Bekavac I; Glavinovic MI; Donati F; Bevan DR
    Anesthesiology; 1992 Aug; 77(2):351-6. PubMed ID: 1353667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rocuronium is the best non-depolarizing relaxant to prevent succinylcholine fasciculations and myalgia.
    Martin R; Carrier J; Pirlet M; Claprood Y; Tétrault JP
    Can J Anaesth; 1998 Jun; 45(6):521-5. PubMed ID: 9669004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of intermediate acting muscle relaxants by infusion: the future.
    Mirakhur RK; McCourt KC; Kumar N
    Acta Anaesthesiol Belg; 1997; 48(1):29-34. PubMed ID: 9099306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fading responses in the evoked EMG after rocuronium in cats.
    Shiraishi H; Suzuki H; Suzuki T; Katsumata N; Ogawa S
    Can J Anaesth; 1992 Dec; 39(10):1099-104. PubMed ID: 1361162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of rocuronium and vecuronium: the pharmacodynamic, cardiovascular and intra-ocular effects.
    Robertson EN; Hull JM; Verbeek AM; Booij LH
    Eur J Anaesthesiol Suppl; 1994; 9():116-21. PubMed ID: 7925202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle relaxants: a clinical update.
    Buzello W; Diefenbach C; Nigrovic V
    Acta Anaesthesiol Scand Suppl; 1996; 109():165-7. PubMed ID: 8901994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular and neuromuscular effects of three steroidal neuromuscular blocking drugs in dogs (ORG 9616, ORG 9426, ORG 9991).
    Cason B; Baker DG; Hickey RF; Miller RD; Agoston S
    Anesth Analg; 1990 Apr; 70(4):382-8. PubMed ID: 1969251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hemodynamic effects of ephedrine on the onset time of rocuronium in pigs.
    Herweling A; Latorre F; Herwig A; Horstick G; Kempski O; Gervais HW
    Anesth Analg; 2004 Dec; 99(6):1703-1707. PubMed ID: 15562058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.